Scholars@Duke
Vance Garrison Fowler Jr.

Vance Garrison Fowler Jr.

Florence McAlister Distinguished Professor of Medicine
Medicine, Infectious Diseases
fowle003@mc.duke.edu
Duke Box 102359, Hanes House, Trent Drive, Durham, NC 27710
Room 183, Hanes House, 315 Trent Drive, Durham, NC 27710

Overview

Determinants of Outcome in Patients with Staphylococcus aureus Bacteremia
Antibacterial Resistance
Pathogenesis of Bacterial Infections
Tropical medicine/International Health

Current Appointments & Affiliations

Florence McAlister Distinguished Professor of Medicine · 2019 - Present Medicine, Infectious Diseases, Medicine
Professor of Medicine · 2012 - Present Medicine, Infectious Diseases, Medicine
Professor in Molecular Genetics and Microbiology · 2012 - Present Molecular Genetics and Microbiology, Basic Science Departments
Member in the Duke Clinical Research Institute · 2001 - Present Duke Clinical Research Institute, Institutes and Centers

In the News

Published August 9, 2023
Synthetic Antibiotic Could Be Effective Against Drug-Resistant Superbugs
Published June 10, 2014
Superbugs, stethoscopes and new technologies to prevent the spread of infection

View All News

Recent Publications

Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: preplanned analysis from CAMERA2.

Journal Article Clin Microbiol Infect · May 2026 OBJECTIVE: Combination antibiotic therapy may improve treatment success for bacterial infections, but bacterial strain-to-strain variability in synergy and its clinical impact remains unclear. This study evaluated whether positive in vitro interactions (sy ... Full text Link to item Cite
View All Publications

Recent Grants

2/3 CTSA K12 Program at Duke University

ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030

Genomic determinants of antibiotic treatment failure in S. aureus bacteremia

ResearchMentor · Awarded by National Institutes of Health · 2024 - 2029

A PHASE 3 EFFICACY AND SAFETY STUDY OF FOSMANOGEPIX FOR THE TREATMENT OF ADULT PARTICIPANTS WITH CANDIDEMIA AND/OR INVASIVE CANDIDIASIS

ResearchInvestigator · Awarded by Basilea Pharmaceutica International Ltd, Allschwil · 2026 - 2028

View All Grants

Education

Duke University · 1999 M.H.S.
University of North Carolina, Chapel Hill · 1993 M.D.